Cinryze Interactions
There are 49 drugs known to interact with Cinryze (C1 esterase inhibitor (human)), along with 1 disease interaction. Of the total drug interactions, 4 are major, 44 are moderate, and 1 is minor.
- View all 49 medications that may interact with Cinryze
- View Cinryze disease interactions (1)
Most frequently checked interactions
View interaction reports for Cinryze (C1 esterase inhibitor (human)) and the medicines listed below.
- Actemra (tocilizumab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Advate (antihemophilic factor)
- Afinitor (everolimus)
- Afrin (oxymetazoline nasal)
- Aldactone (spironolactone)
- Alecensa (alectinib)
- Allegra (fexofenadine)
- alprazolam
- Ambien (zolpidem)
- amoxicillin / clavulanate
- Ampyra (dalfampridine)
- Aralast NP (alpha 1-proteinase inhibitor)
- Aranesp (darbepoetin alfa)
- Augmentin (amoxicillin / clavulanate)
- clarithromycin
- DHEA (dehydroepiandrosterone)
- doxepin
- esomeprazole
- Firazyr (icatibant)
- icatibant
- Ruconest (conestat alfa)
- Sandostatin (octreotide)
- tacrolimus
- Takhzyro (lanadelumab)
- Triumeq (abacavir / dolutegravir / lamivudine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xolair (omalizumab)
Cinryze disease interactions
There is 1 disease interaction with Cinryze (C1 esterase inhibitor (human)) which include:
More about Cinryze (C1 esterase inhibitor (human))
- Cinryze consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.